Aortic Stenosis News and Research RSS Feed - Aortic Stenosis News and Research

Aortic valve replacement now possible without open-heart surgery

Loyola University Medical Center is the first hospital in Illinois to implant a newly approved aortic heart valve device that does not require open surgery. [More]
Boston Scientific presents new data on cardiology-related clinical trials at ACC 2014

Boston Scientific presents new data on cardiology-related clinical trials at ACC 2014

Reinforcing its position as a global leader in bringing new therapies to patients with heart and cardiovascular disease, Boston Scientific Corporation (NYSE: BSX) reported favorable results in studies related to cardiac resynchronization therapy (CRT), platinum chromium stent platforms and transcatheter aortic valve replacement (TAVR). [More]

Study compares two types of heart valve technologies

Among patients undergoing aortic valve replacement using a catheter tube, a comparison of two types of heart valve technologies, balloon-expandable or self-expandable valve systems, found a greater rate of device success with the balloon-expandable valve, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions. [More]
Hepatitis C drug fuels cost debate

Hepatitis C drug fuels cost debate

A panel of experts said this week that the drug represents a "low value" to the health system because of its cost. [More]
First Edition: March 12, 2014

First Edition: March 12, 2014

Today's headlines include stories about the Obama administration's latest tallies regarding how many Americans have signed up for Obamacare coverage and the outcome of a Florida special election that was marked by health law themes. [More]
UH Case Medical Center cardiologists perform TAVR procedure under twilight

UH Case Medical Center cardiologists perform TAVR procedure under twilight

University Hospitals Case Medical Center cardiologists Marco Costa, MD, and Dan Simon, MD, are among the first in the country to perform transaortic valve replacements (TAVR) while the patient is in a "twilight" sedation, awake and communicating with them during the procedure. [More]

FDA approves new artificial heart valve device that does not require major open surgery

An artificial heart valve device that does not require major open surgery has been approved by the Food and Drug Administration. [More]

Prediction models can be useful for heart team to determine best treatment strategy

Detailed prediction models that project long-term patient mortality following percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) surgery can be useful for the heart team when determining the best treatment strategy for individual patients, according to a study in the February 2014 issue of The Annals of Thoracic Surgery. [More]
Gagnon Cardiovascular Institute adopt new medical device to treat patients with severe aortic stenosis

Gagnon Cardiovascular Institute adopt new medical device to treat patients with severe aortic stenosis

The Gagnon Cardiovascular Institute at Morristown Medical Center today became the first hospital in the tri-state area to adopt a new minimally invasive medical device to treat patients with severe aortic stenosis who are too ill or frail to have their aortic valves replaced trough traditional open-heart surgery. [More]
BIDMC receives FDA approval to use new medical device in patients with severely damaged aortic heart valves

BIDMC receives FDA approval to use new medical device in patients with severely damaged aortic heart valves

Beth Israel Deaconess Medical Center (BIDMC) yesterday became the first institution in the United States to use a new minimally invasive medical device since it received FDA approval last week. [More]

TAVI is an effective alternative to AVR for treating aortic stenosis in very elderly patients

Transcatheter aortic valve implantation (TAVI) appears to be an effective alternative to surgical aortic valve replacement (AVR) for the treatment of aortic stenosis in very elderly patients, including those age 85 years and older, according to a study in the January 2014 issue of The Annals of Thoracic Surgery. [More]

Conventional echocardiography increases accuracy of pre-participation sports screening

Echocardiography with conventional M-mode and 2D modalities is a simple and cost effective way to increases the accuracy of pre-participation sports screening, according to research presented at EuroEcho-Imaging 2013 by Dr Alexander Kisko from Presov, Slovakia. [More]

MHIF creates scientific program to address gaps in treating valvular heart disease patients

Despite significant medical advances, there continue to be significant gaps in the health care of the growing number of patients with valvular heart disease. In the USA, the total number of people aged 65 years or older with valvular heart disease will grow to approximately 5.2 million by year 2020, and 6.8 million individuals by the year 2030. The Minneapolis Heart Institute Foundation- has created a scientific program, "Valve Summit 2014: The Science and Delivery of Optimal, Multi-Disciplinary Care," to address the ongoing, complex evolution in the clinical management of patients with valvular heart disease. The conference will be held on April 25th and 26th at the Radisson Blu in downtown Minneapolis. [More]

AATS, cardiovascular professional societies release overview of transcatheter therapies for mitral regurgitation

AATS and three cardiovascular professional societies today released an overview of transcatheter therapies for mitral regurgitation. [More]

MICS CABG procedure safe and feasible, confirms new study

A new study published by The Journal of Thoracic and Cardiovascular Surgery confirms MICS CABG (minimally invasive cardiac surgery/coronary artery bypass grafting) is a safe and feasible procedure that ensures positive outcomes. Published on Nov 1st, the article brings light to the open-heart surgery alternative pioneered by Medical Director and cardiothoracic surgeon, Joseph T. McGinn of The Heart Institute at Staten Island University Hospital. [More]
Latest techniques for diagnosing, treating heart failure to be presented at EuroEcho-Imaging 2013

Latest techniques for diagnosing, treating heart failure to be presented at EuroEcho-Imaging 2013

The latest science on the role of imaging in diagnosing and treating heart failure will be presented at EuroEcho-Imaging 2013, the official annual meeting of the European Association of Cardiovascular Imaging (EACVI), a registered branch of the European Society of Cardiology (ESC). It takes place during 11-14 December in Istanbul, Turkey, at the Istanbul Lutfi Kirdar Convention & Exhibition Centre (ICEC). [More]
Researchers identify link between narrowed heart valves and special lipoprotein in blood

Researchers identify link between narrowed heart valves and special lipoprotein in blood

Researchers at the University of Copenhagen, Herlev Hospital and Rigshospitalet have identified a clear link between narrowed heart valves and a special lipoprotein in the blood. In the long term, the research may well help to prevent valvular heart disease. [More]

Landmark clinical trial of artificial aortic heart valve shows positive results

Loyola University Medical Center is the only Chicago hospital participating in a landmark clinical trial of an artificial aortic heart valve that does not require open heart surgery. [More]

Clinical trial finds COREVALVE reduces rate of death, stroke in patients with aortic stenosis

In a clinical trial, a self-expanding transcatheter aortic valve met the key performance objective of reducing death and stroke in patients with severe aortic stenosis at "extreme risk" for surgery.Results of the COREVALVE EXTREME RISK trial were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. [More]
Bluhm Institute enrolls first patient in SALUS trial to evaluate movable, non-metallic heart valve

Bluhm Institute enrolls first patient in SALUS trial to evaluate movable, non-metallic heart valve

‚ÄčNorthwestern's Bluhm Cardiovascular Institute has enrolled its first participant in SALUS, a clinical trial studying the effectiveness of a prosthetic aortic heart valve that can be placed without open-heart surgery. [More]